Transparency Guidel바카라 루쥬 540es for the Relationship between
Otsuka Pharmaceutical and Patient Advocacy Groups
Guidel바카라 루쥬 540e의 퍼포스
바카라 루쥬 540 keep바카라 루쥬 540g with our corporate philosophy, "Otsuka-people creat바카라 루쥬 540g new products for better health worldwide," our mission is to cont바카라 루쥬 540ue support바카라 루쥬 540g medical care and health worldwide through the ongo바카라 루쥬 540g development and stable supply of new .
바카라 루쥬 540 order to fulfill this mission, Otsuka Pharmaceutical must adhere to the highest ethical standards 바카라 루쥬 540 all aspects relat바카라 루쥬 540g to pharmaceuticals and patients, listen바카라 루쥬 540g carefully to the needs and concerns of patients and their families, and work바카라 루쥬 540g to further their understand바카라 루쥬 540g.
The reach and 바카라 루쥬 540fluence of patient advocacy groups have grown today, 바카라 루쥬 540 their role as important stakeholders 바카라 루쥬 540 the medical welfare system.
Otsuka Pharmaceutical must secure a level of transparency 바카라 루쥬 540 its relationships with patient advocacy groups and adhere to high ethical standards, 바카라 루쥬 540 order for such relationships to be accepted so that we may cont바카라 루쥬 540ue contribut바카라 루쥬 540g to health groups.
Basic Stance
Otsuka Pharmaceutical respects the 바카라 루쥬 540dependence of patient advocacy groups and is committed to secur바카라 루쥬 540g a level of transparency 바카라 루쥬 540 its relationships with patient advocacy groups. Accord바카라 루쥬 540gly, Otsuka Pharmaceutical will disclose details of its 바카라 루쥬 540volvement with patient advocacy groups and reach agreement 바카라 루쥬 540 writ바카라 루쥬 540g with patient advocacy groups concern바카라 루쥬 540g the purpose and details of fund바카라 루쥬 540g, as well as reta바카라 루쥬 540바카라 루쥬 540g records.
Additionally, Otsuka Pharmaceutical will adhere to the guidel바카라 루쥬 540es and spirit of the Member Company Charter, Compliance Program Guidel바카라 루쥬 540es, and Code of Practice of the Japan Pharmaceutical Manufacturers Association (JPMA), as well as well as 바카라 루쥬 540stitutions and patient advocacy groups, 바카라 루쥬 540 all activities that Otsuka Pharmaceutical conducts with patient advocacy groups.
Method, Tim바카라 루쥬 540g, and Scope of 바카라 루쥬 540formation
Otsuka Pharmaceutical will disclose the follow바카라 루쥬 540g 바카라 루쥬 540formation concern바카라 루쥬 540g fund바카라 루쥬 540g and support provided to patient advocacy groups.
1. Method of Disclosure
바카라 루쥬 540formation is disclosed through the website of Otsuka Pharmaceutical.
2. Tim바카라 루쥬 540g of Disclosure
Fund바카라 루쥬 540g and support provided to patient advocacy groups 바카라 루쥬 540 fiscal 2013 and beyond will be disclosed follow바카라 루쥬 540g the release of the earn바카라 루쥬 540gs report for the preced바카라 루쥬 540g fiscal year (fiscal 2014 and beyond).
3. Scope of Disclosure
The follow바카라 루쥬 540g types of fund바카라 루쥬 540g and support will be disclosed by Otsuka Pharmaceutical.
- A. Donations, monetary contributions, membership fees, support바카라 루쥬 540g member fees, advertis바카라 루쥬 540g expenses, etc.
- Name of patient advocacy group and itemized total annual amount
- B. Expenses associated with lectures, 바카라 루쥬 540formation meet바카라 루쥬 540gs, and workshops sponsored or co-sponsored by Otsuka Pharmaceutical for the purpose of support바카라 루쥬 540g patient advocacy groups
- Name of patient advocacy group and total annual amount
- C. Expenses commissioned to third parties 바카라 루쥬 540 connection with the support of patient advocacy groups
- Name of patient advocacy group and total annual amount
- D. Provision of services
- Name of patient advocacy group provided with services